Skip to content

Effect of Steroids on Post-tonsillectomy Morbidities

Effect of Steroids on Post-tonsillectomy Morbidities

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02401529
Enrollment
100
Registered
2015-03-30
Start date
2013-01-31
Completion date
2014-03-31
Last updated
2015-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain, Postoperative Nausea and Vomiting

Keywords

Dexamethasone, Prednisolone, Tonsillectomy Nausea, Pain, Postoperative, Postoperative Nausea and Vomiting, Randomized controlled trial, Post-tonsillectomy pain, delayed feeding

Brief summary

This study aims to evaluate the effect of postoperative systemic rapid onset and short acting dexamethasone followed by a tapering dose of oral prednisolone on post-tonsillectomy morbidities. Half of the patients who comply with the inclusion criteria were selected to receive a single postoperative dose of intravenous dexamethasone followed by oral steroids; the second group received placebo.

Detailed description

The effect of preoperative systemic steroids on post-tonsillectomy morbidities such as pain, nausea, vomiting and delayed feeding was proven. However, this study aims to evaluate the effect of postoperative systemic rapid onset and short acting dexamethasone followed by a tapering dose of oral prednisolone on the aforementioned morbidities and on decreasing the duration and costs of hospital stays. patients who were in the waiting list for tonsillectomy procedure were screened for medical history and those who comply with the inclusion criteria were randomly assigned into two equal groups of 50 patients each. One group was selected to receive a single postoperative dose of intravenous dexamethasone followed by oral steroids; the second group received placebo. Questionnaires investigating postoperative pain, nausea, vomiting, and oral intake were answered by patients, parents or guardians where applicable.

Interventions

0.15 mg/kg

0.25mg/kg/day for 7 days then tapering for next 7 days

DRUGParacetamol

acetaminophen 15 mg/kg/dose every 6 hours

IV saline

Sponsors

King Fahd General Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
5 Years to 20 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients in the waiting list for tonsillectomy under general anesthesia who accepted to participate in the study.

Exclusion criteria

* Patients who are allergic to steroids or those who have medical conditions which contraindicate the use of steroid i.e diabetes mellitus, gastritis, or hypertension and those who were on exogenous steroid supplements.

Design outcomes

Primary

MeasureTime frameDescription
Total Number of Post-operative Vomiting Episodestotal number of post-operative vomiting episodes which were experienced within the 1st week post-surgeryPostoperative vomiting number of attacks (no vomiting,1, 2, 3, if more specify)
Onset of Post-operative Nauseaonset of 1st ocurence of nausea attack within the 1st week post-surgeryPostoperative nausea onset (no nausea, immediate, 1st day, 2nd day, 3rd day, 4th day, 5th day, 6th day, 7th day)
Duration of Post-operative Nausea7 daysPostoperative nausea duration (no nausea,1 day, 2 days, 3 days, 4 days, if more specify)
Occurence of Postoperative Vomiting7 daysPostoperative vomiting occurrence (yes, no)
Maximum Severity of Post-operative PainThe severest pain grade felt within a week5 grades (pain free, low disability and low intensity, low disability and high intensity, high disability and moderate intensity, high disability and severly limiting)
Duration of Post-operative Painnumber of days at which pain was experienced within the the 1st sevn days post -surgery4 selections (1 day, 2 days, 3 days, if more specify)
Occurence of Post-operative Nausea7 daysPostoperative nausea occurence (yes, no)

Secondary

MeasureTime frameDescription
Average Amount of Meal Per Day3 daysadequacy of meals (inadequate, adequate)
Average Frequency of Meals Per Dayaverage number of meals consumed per day for the 1st three days post-surgeryaverage frequency of meals (1 meal, 2 meals, if more specify)
Onset of 1st Post-operative Oral IntakeOnset of 1st post-operative oral intake recorded within the 1st 3days post-surgeryfeeding onset (1st day i. surgery day, 2nd day, 3rd day)

Participant flow

Pre-assignment details

116 participants were initially considered for the study. However, only 100 were considered in the final results. some were excluded due to not matching inclusion criteria. others failed to attend follow up visits, adhere to treatment protocol or complete the questionnaire as required. Please refer to section ( period 1) for further details.

Participants by arm

ArmCount
IV Dexamethasone and Oral Prednisolone
Single dose of intravenous dexamethasone given immediately following surgery (0.15 mg/kg), followed by oral Prednisolone (0.25mg/kg/day for 7 days then tapering for next 7 days) and paracetamol (acetaminophen 15 mg/kg/dose every 6 hours). IV dexamethasone: 0.15 mg/kg Oral prednisolone: 0.25mg/kg/day for 7 days then tapering for next 7 days Paracetamol: acetaminophen 15 mg/kg/dose every 6 hours
50
Placebo
Placebo (IV saline) and paracetamol (acetaminophen 15 mg/kg/dose every 6 hours). Paracetamol: acetaminophen 15 mg/kg/dose every 6 hours IV saline: IV saline
50
Total100

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up21
Overall StudyPhysician Decision26
Overall StudyProtocol Violation50

Baseline characteristics

CharacteristicIV Dexamethasone and Oral PrednisolonePlaceboTotal
Age, Continuous8.5 years8.7 years8.6 years
Sex: Female, Male
Female
16 Participants21 Participants37 Participants
Sex: Female, Male
Male
34 Participants29 Participants63 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 500 / 50
serious
Total, serious adverse events
0 / 500 / 50

Outcome results

Primary

Duration of Post-operative Nausea

Postoperative nausea duration (no nausea,1 day, 2 days, 3 days, 4 days, if more specify)

Time frame: 7 days

ArmMeasureGroupValue (NUMBER)
IV Dexamethasone and Oral PrednisoloneDuration of Post-operative Nauseano nausea33 participants
IV Dexamethasone and Oral PrednisoloneDuration of Post-operative Nauseaone day3 participants
IV Dexamethasone and Oral PrednisoloneDuration of Post-operative Nauseatwo days14 participants
IV Dexamethasone and Oral PrednisoloneDuration of Post-operative Nauseathree days0 participants
PlaceboDuration of Post-operative Nauseathree days6 participants
PlaceboDuration of Post-operative Nauseano nausea21 participants
PlaceboDuration of Post-operative Nauseatwo days15 participants
PlaceboDuration of Post-operative Nauseaone day8 participants
p-value: 0.012Chi-squared
Primary

Duration of Post-operative Pain

4 selections (1 day, 2 days, 3 days, if more specify)

Time frame: number of days at which pain was experienced within the the 1st sevn days post -surgery

ArmMeasureGroupValue (NUMBER)
IV Dexamethasone and Oral PrednisoloneDuration of Post-operative Painone day36 participants
IV Dexamethasone and Oral PrednisoloneDuration of Post-operative Paintwo days11 participants
IV Dexamethasone and Oral PrednisoloneDuration of Post-operative Painthree days3 participants
PlaceboDuration of Post-operative Painone day23 participants
PlaceboDuration of Post-operative Paintwo days19 participants
PlaceboDuration of Post-operative Painthree days8 participants
p-value: 0.026Chi-squared
Primary

Maximum Severity of Post-operative Pain

5 grades (pain free, low disability and low intensity, low disability and high intensity, high disability and moderate intensity, high disability and severly limiting)

Time frame: The severest pain grade felt within a week

ArmMeasureGroupValue (NUMBER)
IV Dexamethasone and Oral PrednisoloneMaximum Severity of Post-operative PainLow disability and low intensity37 participants
IV Dexamethasone and Oral PrednisoloneMaximum Severity of Post-operative Painhigh disability and moderate intensity13 participants
IV Dexamethasone and Oral PrednisoloneMaximum Severity of Post-operative Painhigh disability and high intensity0 participants
PlaceboMaximum Severity of Post-operative PainLow disability and low intensity26 participants
PlaceboMaximum Severity of Post-operative Painhigh disability and moderate intensity21 participants
PlaceboMaximum Severity of Post-operative Painhigh disability and high intensity3 participants
p-value: 0.033Chi-squared
Primary

Occurence of Post-operative Nausea

Postoperative nausea occurence (yes, no)

Time frame: 7 days

ArmMeasureGroupValue (NUMBER)
IV Dexamethasone and Oral PrednisoloneOccurence of Post-operative Nauseano33 participants
IV Dexamethasone and Oral PrednisoloneOccurence of Post-operative Nauseayes17 participants
PlaceboOccurence of Post-operative Nauseayes29 participants
PlaceboOccurence of Post-operative Nauseano21 participants
p-value: 0.016Chi-squared
Primary

Occurence of Postoperative Vomiting

Postoperative vomiting occurrence (yes, no)

Time frame: 7 days

ArmMeasureGroupValue (NUMBER)
IV Dexamethasone and Oral PrednisoloneOccurence of Postoperative Vomitingyes25 participants
IV Dexamethasone and Oral PrednisoloneOccurence of Postoperative Vomitingno25 participants
PlaceboOccurence of Postoperative Vomitingno14 participants
PlaceboOccurence of Postoperative Vomitingyes36 participants
p-value: 0.024Chi-squared
Primary

Onset of Post-operative Nausea

Postoperative nausea onset (no nausea, immediate, 1st day, 2nd day, 3rd day, 4th day, 5th day, 6th day, 7th day)

Time frame: onset of 1st ocurence of nausea attack within the 1st week post-surgery

ArmMeasureGroupValue (NUMBER)
IV Dexamethasone and Oral PrednisoloneOnset of Post-operative Nausea1st day4 participants
IV Dexamethasone and Oral PrednisoloneOnset of Post-operative Nauseaimmediately and 1st day3 participants
IV Dexamethasone and Oral PrednisoloneOnset of Post-operative Nauseano nausea33 participants
IV Dexamethasone and Oral PrednisoloneOnset of Post-operative Nauseaimmediately10 participants
PlaceboOnset of Post-operative Nauseaimmediately8 participants
PlaceboOnset of Post-operative Nausea1st day11 participants
PlaceboOnset of Post-operative Nauseano nausea21 participants
PlaceboOnset of Post-operative Nauseaimmediately and 1st day10 participants
p-value: 0.019Chi-squared
Primary

Total Number of Post-operative Vomiting Episodes

Postoperative vomiting number of attacks (no vomiting,1, 2, 3, if more specify)

Time frame: total number of post-operative vomiting episodes which were experienced within the 1st week post-surgery

ArmMeasureGroupValue (NUMBER)
IV Dexamethasone and Oral PrednisoloneTotal Number of Post-operative Vomiting Episodesonce13 participants
IV Dexamethasone and Oral PrednisoloneTotal Number of Post-operative Vomiting Episodesthree times4 participants
IV Dexamethasone and Oral PrednisoloneTotal Number of Post-operative Vomiting Episodestwice7 participants
IV Dexamethasone and Oral PrednisoloneTotal Number of Post-operative Vomiting Episodesmore than 3 times1 participants
IV Dexamethasone and Oral PrednisoloneTotal Number of Post-operative Vomiting Episodesno vomiting25 participants
PlaceboTotal Number of Post-operative Vomiting Episodesmore than 3 times0 participants
PlaceboTotal Number of Post-operative Vomiting Episodesno vomiting14 participants
PlaceboTotal Number of Post-operative Vomiting Episodesonce9 participants
PlaceboTotal Number of Post-operative Vomiting Episodestwice19 participants
PlaceboTotal Number of Post-operative Vomiting Episodesthree times8 participants
p-value: 0.02Chi-squared
Secondary

Average Amount of Meal Per Day

adequacy of meals (inadequate, adequate)

Time frame: 3 days

ArmMeasureGroupValue (NUMBER)
IV Dexamethasone and Oral PrednisoloneAverage Amount of Meal Per Dayinadequate16 participants
IV Dexamethasone and Oral PrednisoloneAverage Amount of Meal Per Dayadequate34 participants
PlaceboAverage Amount of Meal Per Dayinadequate27 participants
PlaceboAverage Amount of Meal Per Dayadequate23 participants
p-value: 0.026Chi-squared
Secondary

Average Frequency of Meals Per Day

average frequency of meals (1 meal, 2 meals, if more specify)

Time frame: average number of meals consumed per day for the 1st three days post-surgery

ArmMeasureGroupValue (NUMBER)
IV Dexamethasone and Oral PrednisoloneAverage Frequency of Meals Per Day1 meal2 participants
IV Dexamethasone and Oral PrednisoloneAverage Frequency of Meals Per Day2 meals20 participants
IV Dexamethasone and Oral PrednisoloneAverage Frequency of Meals Per Day3 meals28 participants
PlaceboAverage Frequency of Meals Per Day1 meal1 participants
PlaceboAverage Frequency of Meals Per Day2 meals34 participants
PlaceboAverage Frequency of Meals Per Day3 meals15 participants
p-value: 0.019Chi-squared
Secondary

Onset of 1st Post-operative Oral Intake

feeding onset (1st day i. surgery day, 2nd day, 3rd day)

Time frame: Onset of 1st post-operative oral intake recorded within the 1st 3days post-surgery

ArmMeasureGroupValue (NUMBER)
IV Dexamethasone and Oral PrednisoloneOnset of 1st Post-operative Oral Intakesurgery day46 participants
IV Dexamethasone and Oral PrednisoloneOnset of 1st Post-operative Oral Intake1st day after surgery4 participants
PlaceboOnset of 1st Post-operative Oral Intakesurgery day37 participants
PlaceboOnset of 1st Post-operative Oral Intake1st day after surgery13 participants
p-value: 0.017Chi-squared

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026